Dow Up, Moolec Science SA Up
Moolec Science SA shares rose by 3.53 points to end the day at $8.63 per share.
The DOW and S&P gained today while the NASDAQ fell.
The NASDAQ fell 50.48 points.
The DOW rose approximately 48.95 points.
The S&P rose approximately 3.41 points.
The Dow Jones Industrial Average closed modestly higher amid steadying sentiment after encouraging inflation updates helped ease some Wall Street worries about AI's broader impacts on business, allowing for a rebound from recent pressures. The blue-chip index added around 49 points, or 0.1%, to finish near 49,500.93. This came on a relatively calm session despite ongoing tech jitters, with markets closing out the week on a mixed note but showing resilience from encouraging economic signals.
All this as Moolec Science SA shares rose by 3.53 points to end the day at $8.63 per share. The science-based food ingredient company focused on molecular farming for scalable protein solutions stock surged dramatically after announcing positive results from the crushing process of its U.S. GLASO1 safflower platform. The company confirmed gamma-linolenic acid (GLA) concentrations of approximately 45% at commercial scale, following the successful 2025 campaign that covered about 1,100 acres with an average yield of ~2,200 lbs/acre--a 57% year-over-year increase.
The stock opened at $11.17 and traded in a highly volatile range during the session, hitting a high of $12.23 and a low of $8.12, with trading volume exploding to approximately 50,594,700 shares--far exceeding typical daily averages for the micro-cap name. The gain represented a 69.22% increase from the previous close, driven by investor enthusiasm over the milestone validating the platform's operational performance through standard U.S. crushing infrastructure and its potential for high-performance plant-based oils in nutrition and industrial applications.
The outsized performance made Moolec Science SA one of the market's top gainers on a day when broader indices advanced modestly due to stabilizing sentiment and economic data. Investors reacted strongly to the GLA breakthrough as a key validation of the company's molecular farming technology, positioning it for scalable growth in the alternative protein and specialty ingredients sector despite the stock's inherent volatility.